Biomay Announces Expansion of GMP-Facilities to Offer mRNA Manufacturing and Aseptic Filling Services
13.11.2023 14:30:24 CET | news aktuell GmbH | Press release
Vienna, November 13, 2023
Biomay expanded its biomanufacturing facility in central Vienna, 9th district, by adding clean rooms, laboratories, and warehouse premises in the Vienna Competence Center building. Besides the 4000 sqm main site in Vienna 22nd district, Biomay now operates an additional 2000 sqm integrated biomanufacturing facility, equipped with five GMP-commissioned clean rooms for upstream and downstream processing and aseptic filling. Furthermore, the site features comprehensive laboratories for quality control, process and assay development.
A New Center of Excellence for mRNA
The upgraded site will serve as Biomay's Center of Excellence for end-to-end Contract Development and Manufacturing Organization (CDMO) services, specifically for messenger RNA (mRNA) manufacturing. The GMP service offerings for mRNA include plasmid cell banking, circular plasmid and linear DNA template manufacturing, in-vitro transcription (IVT) of mRNA drug substance, and aseptic filling of mRNA drug product. Biomay employs cutting-edge enzymatic run-off transcription based on linear DNA templates for mRNA processing, offering various options for 5´-capping, 3´-poly-adenylation, and nucleotide modification as per client requirements.
Notably, Biomay has a strong track record in GMP production of linear DNA templates, supplying significant amounts of these templates during the COVID-19 pandemic for the manufacturing of a COVID-19 mRNA vaccine. The company has also gained extensive experience in GMP manufacturing of DNA templates for other clinical indications, such as oncology.
Aseptic Filling Capacities
Biomay's aseptic filling capacities include a seven-glove isolator equipped with an automated processing line for aseptic filling, vial capping and crimping, primarily serving clinical-stage investigational medicinal products (IMPs). Dr. Angela Neubauer, the Site Head of the facility and Biomay's Senior Vice President Client Business, emphasized the company's evolution from being a drug substance and API manufacturer to offering drug product aseptic filling, testing and release services. She highlighted Biomay's strategic goal of establishing itself as a leading player in the mRNA CDMO field, alongside its existing expertise in proteins and plasmids.
Contacts
Dr. Angela NeubauerSVP Client BusinessBiomay AG
Ada Lovelace-Str. 2
A-1220 Vienna, Austria
Images
Links
About Biomay
Founded in 1984, Biomay AG is a fully integrated CDMO with a focus on microbial based GMP services for manufacturing therapeutic proteins, plasmid DNA and mRNA. The new site complements Biomay’s main manufacturing site in Vienna Seestadt (22nd district, Ada Lovelace-Strasse), established in 2021.
About news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Democracy News Alliance: Elections will determine whether Israel remains the Middle East’s only democracy, new report says16.10.2026 12:58:26 CEST | Press release
Los Angeles/DNA - For the first time since the Hamas attacks of three years ago, Israel is set to go to the polls on October 27 to elect the members of the 26th Knesset. In 2023 the country was in the top group of ‘consolidated democratic states’, according to the 2026 Berggruen Governance Index (BGI), just as it had been in 2000. However, according to a new report from governance experts, the wars unleashed on multiple fronts in rapid succession following the Hamas attacks launched from Gaza have changed Israel politically, economically, and socially.
S&D Conference on Quality Jobs: Europe must protect workers through the digital transition16.10.2026 08:58:12 CEST | Press release
Brussels – The Socialists and Democrats (S&D) Group in the European Parliament is stepping up political pressure for an ambitious European framework for quality jobs. At the “Quality Jobs for All” conference in Brussels on 14 October, the impact of artificial intelligence, digital surveillance, precarious employment conditions and growing work-related stress was at the centre of the debate. The conference took place as the European Commission is expected to present its proposal for a Quality Jobs Act in December 2026. Quality Jobs for All is one of the S&D Group’s six flagship political priorities, set out under their Strategic Turn initiative in recent months. Jobs and the labour markets are changing rapidly, with automation and artificial intelligence able to fundamentally change professions and their inherent activities. At the same time, concerns are growing about job cuts, wage pressure, social exclusion and the loss of workers’ voices at work. Experts at the conference have warne
Amid Mounting Global Health Crises, World Health Summit Closes in Berlin with New Commitments14.10.2026 14:43:09 CEST | Press release
Berlin, October 14, 2026 - The World Health Summit 2026 concluded with new funding commitments, research findings, and initiatives. Under the theme “From Crisis to Resilience: Innovating for Health,” the Summit convened more than 4,000 on-site participants from 130 countries and territories, generated over 50,000 livestream views, and featured more than 400 speakers, including 20 ministers and state secretaries, across 76 sessions.
Innomotics Receives Prestigious EcoVadis Silver Medal – First Assessment Places Company Among Top 15% Globally12.10.2026 12:00:00 CEST | Press release
Nuremberg – Innomotics, a globally leading provider of electric motors and large drive systems, has earned the coveted EcoVadis Silver Medal in its first-ever assessment. With a strong score of 74 out of 100 points, the company now ranks among the global top 15% of more than 150,000 rated companies. First EcoVadis Rating as Innomotics Participation in the EcoVadis assessment marks an important milestone in Innomotics’ sustainability journey. As a relatively young, independent organization, the first rating provided the opportunity to benchmark its sustainability management against an internationally recognized framework and demonstrate the progress made since becoming a standalone company. Silver Medal: Top 15% Globally The EcoVadis Silver Medal is awarded to the top 15% of companies assessed worldwide. With its achieved score of 74 points, Innomotics not only confirms its position within this leading group but also demonstrates that it meets the rating’s rising requirements – the thre
World Health Summit 2026: Berlin Becomes Global Meeting Point for the Future of Health12.10.2026 08:43:40 CEST | Press release
Berlin, October 11, 2026 The World Health Summit (WHS) 2026, the leading platform for global health, brings together more than 4,000 participants from 130 countries in Berlin and tens of thousands more online from October 11 to 13. Under the theme "From Crisis to Resilience: Innovating for Health," the Summit convenes leaders from politics, science, civil society, and the private sector. Discussions address Ebola and other infectious diseases, antibiotic resistance, pandemic preparedness, resilient health systems, health care in conflict settings such as Ukraine, and climate-related health threats. The Summit will also address WHO leadership through a conversation with prospective candidates for the next WHO Director-General.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom